Premium
Topiramate‐Responsive Headache Due to Idiopathic Intracranial Hypertension in Behçet Syndrome
Author(s) -
Palacio Enrique,
Rodero Lucia,
Pascual Julio
Publication year - 2004
Publication title -
headache: the journal of head and face pain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.14
H-Index - 119
eISSN - 1526-4610
pISSN - 0017-8748
DOI - 10.1111/j.1526-4610.2004.04095.x
Subject(s) - topiramate , headaches , medicine , pseudotumor cerebri , acetazolamide , cerebrospinal fluid , anesthesia , pediatrics , epilepsy , surgery , intracranial pressure , psychiatry
A 14‐year‐old adolescent was seen with an 8‐month history of almost daily incapacitating headaches due to idiopathic intracranial hypertension in Behçet syndrome. All his clinical signs and symptoms, including headache, resolved 2 to 4 weeks after topiramate was initiated. An effect on carbonic anhydrase isoenzymes II and IV, reducing cerebrospinal fluid production, could potentially explain the beneficial effect of topiramate in intracranial hypertension. Further studies are necessary, however, to confirm the significance of topiramate in this indication.